130 related articles for article (PubMed ID: 28513984)
1. sPD-L1 Expression is Associated with Immunosuppression and Infectious Complications in Patients with Acute Pancreatitis.
Chen Y; Li M; Liu J; Pan T; Zhou T; Liu Z; Tan R; Wang X; Tian L; Chen E; Qu H
Scand J Immunol; 2017 Aug; 86(2):100-106. PubMed ID: 28513984
[TBL] [Abstract][Full Text] [Related]
2. Monocyte programmed death ligand-1 expression is an early marker for predicting infectious complications in acute pancreatitis.
Pan T; Zhou T; Li L; Liu Z; Chen Y; Mao E; Li M; Qu H; Liu J
Crit Care; 2017 Jul; 21(1):186. PubMed ID: 28705256
[TBL] [Abstract][Full Text] [Related]
3. Serum soluble PD-1 plays a role in predicting infection complications in patients with acute pancreatitis.
Yu X; Pan Y; Fei Q; Lin X; Chen Z; Huang H
Immun Inflamm Dis; 2021 Mar; 9(1):310-318. PubMed ID: 33417300
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of soluble programmed death ligand 1 predict treatment response and progression free survival in multiple myeloma.
Wang L; Wang H; Chen H; Wang WD; Chen XQ; Geng QR; Xia ZJ; Lu Y
Oncotarget; 2015 Dec; 6(38):41228-36. PubMed ID: 26515600
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer.
Takahashi N; Iwasa S; Sasaki Y; Shoji H; Honma Y; Takashima A; Okita NT; Kato K; Hamaguchi T; Yamada Y
J Cancer Res Clin Oncol; 2016 Aug; 142(8):1727-38. PubMed ID: 27256004
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of soluble programmed death-1 (sPD-1) and soluble programmed death ligand 1(sPD-L1) in systemic lupus erythematosus: Association with activity and severity.
Du Y; Nie L; Xu L; Wu X; Zhang S; Xue J
Scand J Immunol; 2020 Jul; 92(1):e12884. PubMed ID: 32243638
[TBL] [Abstract][Full Text] [Related]
7. Inverse correlation of soluble programmed cell death-1 ligand-1 (sPD-L1) with eosinophil count and clinical severity in allergic rhinitis patients.
Nasiri Kalmarzi R; Fattahi N; Kaviani Z; Ataee P; Mansouri M; Moradi G; Yousefzade A; Abbassi JM
Allergol Int; 2017 Apr; 66(2):326-331. PubMed ID: 27617656
[TBL] [Abstract][Full Text] [Related]
8. Mononuclear histocompatibility leukocyte antigen-DR expression in the early phase of acute pancreatitis.
Yu WK; Li WQ; Li N; Li JS
Pancreatology; 2004; 4(3-4):233-43. PubMed ID: 15166475
[TBL] [Abstract][Full Text] [Related]
9. Serum sPD-L1, Upregulated in Sepsis, May Reflect Disease Severity and Clinical Outcomes in Septic Patients.
Liu M; Zhang X; Chen H; Wang G; Zhang J; Dong P; Liu Y; An S; Wang L
Scand J Immunol; 2017 Jan; 85(1):66-72. PubMed ID: 27864994
[TBL] [Abstract][Full Text] [Related]
10. High plasma levels of soluble programmed cell death ligand 1 are prognostic for reduced survival in advanced lung cancer.
Okuma Y; Hosomi Y; Nakahara Y; Watanabe K; Sagawa Y; Homma S
Lung Cancer; 2017 Feb; 104():1-6. PubMed ID: 28212990
[TBL] [Abstract][Full Text] [Related]
11. Development of a sandwich ELISA for evaluating soluble PD-L1 (CD274) in human sera of different ages as well as supernatants of PD-L1+ cell lines.
Chen Y; Wang Q; Shi B; Xu P; Hu Z; Bai L; Zhang X
Cytokine; 2011 Nov; 56(2):231-8. PubMed ID: 21733718
[TBL] [Abstract][Full Text] [Related]
12. Evidence for Persistent Immune Suppression in Patients Who Develop Chronic Critical Illness After Sepsis.
Stortz JA; Murphy TJ; Raymond SL; Mira JC; Ungaro R; Dirain ML; Nacionales DC; Loftus TJ; Wang Z; Ozrazgat-Baslanti T; Ghita GL; Brumback BA; Mohr AM; Bihorac A; Efron PA; Moldawer LL; Moore FA; Brakenridge SC
Shock; 2018 Mar; 49(3):249-258. PubMed ID: 28885387
[TBL] [Abstract][Full Text] [Related]
13. High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis.
Finkelmeier F; Canli Ö; Tal A; Pleli T; Trojan J; Schmidt M; Kronenberger B; Zeuzem S; Piiper A; Greten FR; Waidmann O
Eur J Cancer; 2016 May; 59():152-159. PubMed ID: 27039170
[TBL] [Abstract][Full Text] [Related]
14. [Increased serum levels of soluble programmed death-1 (sPD-1) and sPD-ligand 1 in patients infected with Brucella].
Pang P; Zhu Y; Jia B; Yang Y; Hu J; Zhang Y; Zhang F; Ding J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Dec; 32(12):1675-1678. PubMed ID: 27916101
[TBL] [Abstract][Full Text] [Related]
15. Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction.
Okuyama M; Mezawa H; Kawai T; Urashima M
Front Immunol; 2019; 10():86. PubMed ID: 30833943
[No Abstract] [Full Text] [Related]
16. Serum levels of soluble programmed death-1 and programmed death ligand-1 in systemic sclerosis: Association with extent of skin sclerosis.
Yanaba K; Hayashi M; Yoshihara Y; Nakagawa H
J Dermatol; 2016 Aug; 43(8):954-7. PubMed ID: 26945563
[TBL] [Abstract][Full Text] [Related]
17. [Soluble programmed death-1 and soluble programmed death ligand 1 protein expression and immune status in patients with recurrent aphthous ulcer].
Nan J; Liang L; Li L; Xiaoqin S; Xing J; Yang C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2017 Jun; 35(3):286-290. PubMed ID: 28675014
[TBL] [Abstract][Full Text] [Related]
18. Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T-cell lymphomas.
Zhang X; Liu L; Zhou S; Zhao K; Song Z; Hu G; Zhang T; Li Y; Qiu L; Li L; Qian Z; Meng B; Pan Y; Ren X; Wang X; Zhang H; Fu K
Hematol Oncol; 2019 Aug; 37(3):270-276. PubMed ID: 31074879
[TBL] [Abstract][Full Text] [Related]
19. Increased PD-1 on CD4(+)CD28(-) T cell and soluble PD-1 ligand-1 in patients with T2DM: association with atherosclerotic macrovascular diseases.
Shi B; Du X; Wang Q; Chen Y; Zhang X
Metabolism; 2013 Jun; 62(6):778-85. PubMed ID: 23398844
[TBL] [Abstract][Full Text] [Related]
20. Serum-soluble PD-L1 may be a potential diagnostic biomarker in sepsis.
Sun S; Chen Y; Liu Z; Tian R; Liu J; Chen E; Mao E; Pan T; Qu H
Scand J Immunol; 2021 Jul; 94(1):e13049. PubMed ID: 33934376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
